MENU
GLTO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Galecto (GLTO) Ownership - Who owns Galecto?
Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of fibrosis and impact a broad range of fibrotic and related diseases, including cancer... Show more
Profile
Industry
N/A
Address
Ole Maaloes Vej 3
Phone
+45 70705210
Employees
13
Web
https://www.galecto.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.78M
P/E Ratio
N/A
Total Cash
19.68M
Projected Growth
N/A
Total Debt
32K
Revenue
N/A
Risk (Beta)
1.38
Dividend Yield
N/A
Total Cash/Share
14.88
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
GLTO
Capitalization
3.78M
P/E Ratio
N/A
Risk (Beta)
1.38
Dividend Yield
N/A
Total Cash
19.7M
Total Cash/Share
14.88
Total Debt
32K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
20.9M
P/B Ratio
0.30
Cash Flow
N/A
Earnings
-19.11
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
8.68
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-19.68M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-57.67
Shares Held By Institutions
725K
Shares Outstanding - Current
1.32M
Total Liabilities
2.44M
Total Volume MTD
N/A
Value
1
Gain YTD
-38.495
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Ole Maaloes Vej 3
Phone
+45 70705210
Employees
13
Web
https://www.galecto.com